Search Results

You are looking at 1 - 1 of 1 items for :

  • Author or Editor: Hussni O. Mohammed x
  • Pharmacology x
  • Refine by Access: All Content x
Clear All Modify Search


The isoflurane-sparing effect of the α2-adrenergic agonist medetomidine (30 μg/kg of body weight, IV) was tested in 7 dogs, using a blinded, randomized-block study design. The baseline minimal alveolar concentration (mac) of isoflurane was 1.18 vol% (95% confidence interval [097,1.39])- Medetomidine significantly (P < 0.003) reduced isoflurane mac by 47.2%. Atipamezolc (0.3 mg/kg, iv), an α2-adrenergic antagonist, completely reversed the effect of mcdetomidine on isoflurane mac. Atipamezole alone did not significantly alter isoflurane mac.

After medetomidine administration, marked bradycardia developed in all dogs and persisted for more than 2 hours Mean arterial blood pressure increased acutely, but later decreased, and hypotension persisted for more than 2 hours. Atipamezole reversed the bradycardic and hypotensive effects of medetomidine.

Results of this study indicate that medetomidine mav be useful in clinical cases in which isoflurane mac-reduction is desirable and that atipamezole might be used to reverse desirable and undesirable effects of medetomidine during isoflurane anesthesia.

Free access
in American Journal of Veterinary Research